Coherus Oncology (CHRS.US) — market event timeline

nashnova tracks 1 market event mentioning Coherus Oncology (CHRS.US) as of 2026-10-12, each with a dated one-line analysis of how the event relates to the asset.

1. 2026-10-12Bristol-Myers Squibb Hits Primary Endpoints in Two Phase 3 Trials, Shares Up Nearly 6% Premarket

   RYZ101 originated from Point Biopharma (which collaborated with BMY before being acquired by Eli Lilly); attention on competitors in the neuroendocrine tumor space rises accordingly.

For research and information only — not investment advice.